相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™
Patricia Kelly et al.
MICROCIRCULATION (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Human apolipoprotein E ε4 expression impairs cerebral vascularization and blood-brain barrier function in mice
Wael Alata et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Jose Luis Molinuevo et al.
ALZHEIMERS & DEMENTIA (2014)
The future of blood-based biomarkers for Alzheimer's disease
Kim Henriksen et al.
ALZHEIMERS & DEMENTIA (2014)
Developing novel blood-based biomarkers for Alzheimer's disease
Heather M. Snyder et al.
ALZHEIMERS & DEMENTIA (2014)
Biological markers of Alzheimer's disease
Leonardo Cruz de Souza et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2014)
Alzheimer's Disease: New Data Highlight Nonneuronal Cell Types and the Necessity for Presymptomatic Prevention Strategies
Sam Gandy
BIOLOGICAL PSYCHIATRY (2014)
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease?
Ethan A. Winkler et al.
BRAIN PATHOLOGY (2014)
Myelin Injury and Degraded Myelin Vesicles in Alzheimer's Disease
Xinhua Zhan et al.
CURRENT ALZHEIMER RESEARCH (2014)
Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain
Ahmed A. Saeed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice
Hyung Jin Ahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2
Milene Vandal et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a Comparative Overview
Frederic Brosseron et al.
MOLECULAR NEUROBIOLOGY (2014)
Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow
Hongmei Li et al.
MOLECULAR NEURODEGENERATION (2014)
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity
C. Hammer et al.
MOLECULAR PSYCHIATRY (2014)
Crystal structure of the human glucose transporter GLUT1
Dong Deng et al.
NATURE (2014)
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ayal Ben-Zvi et al.
NATURE (2014)
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Long N. Nguyen et al.
NATURE (2014)
Capillary pericytes regulate cerebral blood flow in health and disease
Catherine N. Hall et al.
NATURE (2014)
Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults
Adam M. Brickman et al.
NATURE NEUROSCIENCE (2014)
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
Lidia Glodzik et al.
NEUROBIOLOGY OF AGING (2014)
Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders
Sharmilee Gnanapavan et al.
NEUROLOGY (2014)
Biomarkers for neurology Guides and lines
John O. Fleming et al.
NEUROLOGY (2014)
Recommendations of the Alzheimer's Disease-Related Dementias Conference
T. J. Montine et al.
NEUROLOGY (2014)
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko et al.
NEUROLOGY (2014)
Prevalence of cortical superficial siderosis in a memory clinic population
Hazel I. Zonneveld et al.
NEUROLOGY (2014)
Blood-Brain Barrier: A Dual Life of MFSD2A?
Zhen Zhao et al.
NEURON (2014)
Alzheimer's Disease Genetics: From the Bench to the Clinic
Celeste M. Karch et al.
NEURON (2014)
DIFFUSION TENSOR IMAGING OF WHITE MATTER DEGENERATION IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
I. K. Amlien et al.
NEUROSCIENCE (2014)
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease
Frank Martin Schmidt et al.
NEUROSCIENCE LETTERS (2014)
Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease
Alfred N. Fonteh et al.
PLOS ONE (2014)
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice
Ethan A. Winkler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Clinical Predictors of Severe Cerebral Amyloid Angiopathy and Influence of APOE Genotype in Persons With Pathologically Verified Alzheimer Disease
John M. Ringman et al.
JAMA NEUROLOGY (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI
S. P. Cramer et al.
NEUROIMAGE-CLINICAL (2014)
DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial
Welma Stonehouse et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia
Laura F. DeFina et al.
ANNALS OF INTERNAL MEDICINE (2013)
Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice
Angela Allen et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes
Alan Rembach et al.
BIOMARKERS IN MEDICINE (2013)
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre
Jon B. Toledo et al.
BRAIN (2013)
Deficiency in Mural Vascular Cells Coincides with Blood-Brain Barrier Disruption in Alzheimer's Disease
Jesse D. Sengillo et al.
BRAIN PATHOLOGY (2013)
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Marie-Victoire Guillot-Sestier et al.
CNS & Neurological Disorders-Drug Targets (2013)
Glial Influence on the Blood Brain Barrier
Jorge Ivan Alvarez et al.
GLIA (2013)
The APOE ε4/ε4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients
Karin Hultman et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents
Lisa Mosconi et al.
NEUROBIOLOGY OF AGING (2013)
Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8)
Xuezhu Zhang et al.
NEUROLOGICAL SCIENCES (2013)
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia
Rik Ossenkoppele et al.
NEUROLOGY (2013)
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M. Roe et al.
NEUROLOGY (2013)
Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults
Daniel A. Nation et al.
NEUROLOGY (2013)
ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function
Jaehong Suh et al.
NEURON (2013)
Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene
Atsushi Niwa et al.
NEUROPATHOLOGY (2013)
New Insights into the Dementia Epidemic
Eric B. Larson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Innate immunity receptor CD36 promotes cerebral amyloid angiopathy
Laibaik Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration
Jeriel T. R. Keeney et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Research Priority Setting A Summary of the 2012 NINDS Stroke Planning Meeting Report
Barbara G. Vickrey et al.
STROKE (2013)
Pericyte loss influences Alzheimer-like neurodegeneration in mice
Abhay P. Sagare et al.
NATURE COMMUNICATIONS (2013)
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's disease
Wilfred A. Jefferies et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism
Thaddeus J. Haight et al.
JAMA NEUROLOGY (2013)
Relationship Between Cyclophilin A Levels and Matrix Metalloproteinase 9 Activity in Cerebrospinal Fluid of Cognitively Normal Apolipoprotein E4 Carriers and Blood-Brain Barrier Breakdown
Matthew R. Halliday et al.
JAMA NEUROLOGY (2013)
Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease
Hillary D. Protas et al.
JAMA NEUROLOGY (2013)
Cerebrovascular Effects of Apolipoprotein E Implications for Alzheimer Disease
Berislav V. Zlokovic
JAMA NEUROLOGY (2013)
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging
Talia M. Nir et al.
NEUROIMAGE-CLINICAL (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis
Rui Liu et al.
BMC MEDICINE (2012)
Fibrinogen-induced increased pial venular permeability in mice
Nino Muradashvili et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability
Ethan A. Winkler et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Plasmin system of Alzheimer's disease patients: CSF analysis
Alessandro Martorana et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease
Julius Popp et al.
JOURNAL OF NEUROCHEMISTRY (2012)
LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2012)
Does vascular pathology contribute to Alzheimer changes?
Raj N. Kalaria et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy
Stavros J. Baloyannis et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Cerebral microinfarcts: the invisible lesions
Eric E. Smith et al.
LANCET NEUROLOGY (2012)
Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly
Lidia Glodzik et al.
NEUROBIOLOGY OF AGING (2012)
Injury and repair in the neurovascular unit
Changhong Xing et al.
NEUROLOGICAL RESEARCH (2012)
Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele
Cheryl A. Hawkes et al.
PLOS ONE (2012)
Preventing Alzheimer's Disease
Dennis J. Selkoe
SCIENCE (2012)
The Genetics of Alzheimer Disease
Rudolph E. Tanzi
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Cerebral blood flow in Alzheimer's disease
Alex E. Roher et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
Markedly Elevated Soluble Intercellular Adhesion Molecule 1, Soluble Vascular Cell Adhesion Molecule 1 Levels, and Blood-Brain Barrier Breakdown in Neuromyelitis Optica
Akiyuki Uzawa et al.
ARCHIVES OF NEUROLOGY (2011)
Chemokines in CSF of Alzheimer's disease patients
Joice Dias Correa et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2011)
Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats
Fanrui Meng et al.
BRAIN RESEARCH (2011)
Vascular signaling abnormalities in Alzheimer disease
P. GRAMMAS et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E. Genin et al.
MOLECULAR PSYCHIATRY (2011)
Quantitative Measurement of Blood-Brain Barrier Permeability in Human Using Dynamic Contrast-Enhanced MRI with Fast T1 Mapping
Saeid Taheri et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Central nervous system pericytes in health and disease
Ethan A. Winkler et al.
NATURE NEUROSCIENCE (2011)
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
Rebecca Craig-Schapiro et al.
PLOS ONE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick et al.
STROKE (2011)
Microinfarct Pathology, Dementia, and Cognitive Systems
Zoe Arvanitakis et al.
STROKE (2011)
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors
K. Blennow et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
William T. Hu et al.
ACTA NEUROPATHOLOGICA (2010)
Age-Related Vascular Pathology in Transgenic Mice Expressing Presenilin 1-Associated Familial Alzheimer's Disease Mutations
Miguel A. Gama Sosa et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Glut1/SLC2A1 Is Crucial for the Development of the Blood-Brain Barrier In Vivo
Ping-Pin Zheng et al.
ANNALS OF NEUROLOGY (2010)
APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging
Madhav Thambisetty et al.
ARCHIVES OF NEUROLOGY (2010)
Biomarkers in Alzheimer's disease: past, present and future
Katarzyna Gustaw-Rothenburg et al.
BIOMARKERS IN MEDICINE (2010)
Pericytes regulate the blood-brain barrier
Annika Armulik et al.
NATURE (2010)
Pericytes are required for blood-brain barrier integrity during embryogenesis
Richard Daneman et al.
NATURE (2010)
Neurodegeneration and the neurovascular unit
Berislav V. Zlokovic
NATURE MEDICINE (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
Liana G. Apostolova et al.
NEUROBIOLOGY OF AGING (2010)
Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
Robert D. Bell et al.
NEURON (2010)
Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization
Hyung Jin Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy
Roy O. Weller et al.
ACTA NEUROPATHOLOGICA (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain
Jae K. Ryu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Measurement of Brain Perfusion, Blood Volume, and Blood-Brain Barrier Permeability, Using Dynamic Contrast-Enhanced T1-Weighted MRI at 3 Tesla
Henrik B. W. Larsson et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Richard J. Perrin et al.
NATURE (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms
Kimio Satoh et al.
NATURE MEDICINE (2009)
Biomarkers of Alzheimer's disease
Rebecca Craig-Schapiro et al.
NEUROBIOLOGY OF DISEASE (2009)
Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study
John M. Starr et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
The Neurovascular Unit in Health and Disease Introduction
Eng H. Lo et al.
STROKE (2009)
Patients With Alzheimer Disease With Multiple Microbleeds Relation With Cerebrospinal Fluid Biomarkers and Cognition
Jeroen D. C. Goos et al.
STROKE (2009)
Detection of Isolated Cerebrovascular β-Amyloid with Pittsburgh Compound B
Steven M. Greenberg et al.
ANNALS OF NEUROLOGY (2008)
Clinical and neuropathological features of the Arctic APP gene mutation causing early-onset Alzheimer disease
Hans Basun et al.
ARCHIVES OF NEUROLOGY (2008)
Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice
Arne Herring et al.
BRAIN PATHOLOGY (2008)
Hypertension and cerebrovascular dysfunction
Costantino Iadecola et al.
CELL METABOLISM (2008)
apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
Justin Paul et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
B. D. Zipser et al.
NEUROBIOLOGY OF AGING (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Henrietta M. Nielsen et al.
NEUROBIOLOGY OF DISEASE (2007)
Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches
Bianca Van Broeck et al.
NEURODEGENERATIVE DISEASES (2007)
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD
M. Yoshita et al.
NEUROLOGY (2006)
Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis
Scott A. Small et al.
NEURON (2006)
Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases
Elike Bogaert et al.
MUSCLE & NERVE (2006)
Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls
Huali Wang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Reduction of amyloid angiopathy and Aβ plaque burden after enriched housing in TgCRND8 mice -: Involevement of multiple pathways
Oliver Ambree et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease
D Galimberti et al.
ARCHIVES OF NEUROLOGY (2006)
Increased levels of CSF phosphorylated tau in apolipoprotein E ε4 carriers with mild cognitive impairment
K Buerger et al.
NEUROSCIENCE LETTERS (2005)
Pericapillary haem-rich deposits:: evidence for microhaemorrhages in aging human cerebral cortex
KM Cullen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Decline of immune responsiveness: A pathogenetic factor in Alzheimer's disease?
E Richartz et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls
S Kumar-Singh et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Cerebrospinal fluid tau, Aβ1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia
JP Jia et al.
NEUROSCIENCE LETTERS (2005)
Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study
A Ruitenberg et al.
ANNALS OF NEUROLOGY (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice
O Lazarov et al.
CELL (2005)
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience
NA Johnson et al.
RADIOLOGY (2005)
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
ZH Wu et al.
NATURE MEDICINE (2005)
Glucose transporter plasticity during memory processing
C Choeiri et al.
NEUROSCIENCE (2005)
Neurovascular regulation in the normal brain and in Alzheimer's disease
C Iadecola
NATURE REVIEWS NEUROSCIENCE (2004)
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
JA Schneider et al.
NEUROLOGY (2004)
Oxidative stress signalling in Alzheimer's disease
XW Zhu et al.
BRAIN RESEARCH (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
D Paris et al.
NEUROSCIENCE LETTERS (2004)
Value of CSF β-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
H Hampel et al.
MOLECULAR PSYCHIATRY (2004)
Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease:: The effect of APOE ε4 allele
T Sunderland et al.
BIOLOGICAL PSYCHIATRY (2004)
Intrathecal inflammation precedes development of Alzheimer's disease
E Tarkowski et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1
E Dömötör et al.
BLOOD (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease
S Salloway et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
K Buerger et al.
NEUROLOGY (2002)
Activated protein C:: Potential therapy for severe sepsis, thrombosis, and stroke
JH Griffin et al.
SEMINARS IN HEMATOLOGY (2002)
Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood
OR Monro et al.
NEUROBIOLOGY OF AGING (2002)
Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier
M Fiala et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients
YY Hu et al.
NEUROSCIENCE LETTERS (2002)
Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein
K Niwa et al.
NEUROBIOLOGY OF DISEASE (2002)
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia
E Tarkowski et al.
NEUROBIOLOGY OF AGING (2002)
Alzheimer disease and cerebrovascular pathology: an update
KA Jellinger
JOURNAL OF NEURAL TRANSMISSION (2002)
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease
ER Peskind et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
M Sjögren et al.
NEUROLOGY (2000)
分享论文
